Multisystem inflammatory syndrome in children and adults
MONDO:0035375Also known as: MIS-C/A
7 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Experimental stem cells offered to kids with rare COVID complication
Disease control NO_LONGER_AVAILABLEThis study provides early access to an experimental stem cell treatment called remestemcel-L for children aged 2 months to 17 years with MIS-C, a severe inflammatory condition linked to COVID-19. The treatment aims to calm the immune system and reduce inflammation. Participants r…
Sponsor: Mesoblast International Sàrl • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Tracking Kids' hearts years after rare COVID-19 complication
Knowledge-focused OngoingThis study follows 1,200 children and young adults who had MIS-C, a rare inflammatory condition linked to COVID-19. Researchers will track heart function and other health outcomes over time using echocardiograms and medical records. The goal is to understand the long-term effects…
Sponsor: Carelon Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Can we cut back on bladder drugs for seniors? new study aims to find out
Knowledge-focused OngoingThis study tests a guideline designed to help doctors safely reduce or stop overactive bladder medications in people aged 65 and older. Researchers will compare how many patients continue these drugs after six months between those whose doctors follow the guideline and those who …
Phase: NA • Sponsor: Anne Estrup Olesen • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC